NCT00848536 - Efficacy Study of Travoprost APS Versus TRAVATAN | Biotech Hunter

Enrollment

371

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions

Open Angle GlaucomaOcular Hypertension

Interventions

DRUG

Travoprost 0.004% (POLYQUAD-preserved) Eye Drops, Solution

One drop once daily in the evening for 3 months

DRUG

Travoprost 0.004% (BAK-preserved) Eye Drops, Solution

One drop once daily in the evening for 3 months